Targeted for Corporate Purchasing Managers, Technical Directors, and Operations Leaders who demand high‑purity, GMP‑certified peptide APIs at a price that protects ROI.
Our Powerful Factory combines ISO 9001, GMP, and FDA‑approved processes to guarantee batch‑to‑batch consistency, while our OEM/ODM design service tailors the hormone to your exact assay requirements.
Get Free Sample & Quote in 24 hEven the most sophisticated diabetes research teams encounter the same three bottlenecks:
According to a 2025 industry survey (n = 312), 57 % of R&D directors cited “supplier cost & quality” as the top reason for project postponement. Imagine the cumulative loss: a single missed trial can cost **$2‑3 million** in sunk expenses.
| Parameter | Our Product | Typical Competitor |
|---|---|---|
| Purity (HPLC) | ≥ 99.5 % | 90‑95 % |
| Certificate of Analysis | Full‑traceable, third‑party verified | In‑house only |
| Lead Time (Standard) | 7 days production + 2 days shipping | 45‑60 days total |
| Price (USD/gram, 100 g batch) | $120 ± 5 % | $180 ± 10 % |
| Shipping Cost (USA) | $30 (Express) | $80 (Standard) |
Start your cost‑saving order today →
Scenario 1 – GLP‑1 Receptor Agonist Screening: A US biotech firm reduced assay variability from 12 % to 2 % after switching to our 99.5 % pure hormone, cutting repeat‑test costs by **$45 K** per project.
Scenario 2 – Pre‑clinical Pharmacokinetic (PK) Modeling: Our fast‑track 7‑day delivery enabled a Phase I study to start on schedule, shortening the overall development timeline by **3 months** and saving an estimated **$1.2 M** in overhead.
Scenario 3 – Custom Peptide Conjugates: Using our OEM service, a CRO produced a dual‑incretin construct (GLP‑1 + GIP) at a 20 % lower cost than in‑house synthesis, accelerating the go‑to‑market plan for a next‑generation diabetes therapy.
Our Incretin hormone is **≥ 99.5 % pure** as determined by HPLC, LC‑MS, and amino‑acid analysis performed by an **ISO‑17025 accredited** third‑party laboratory. A full Certificate of Analysis (CoA) is issued for every batch.

Yes. Our R&D team can design custom linkers, modify terminal residues, or scale the synthesis from 10 mg to 10 kg. Turn‑around time for custom projects is typically **15‑25 days** after final specification approval.
We accept T/T (30 % advance, 70 % against copy of Bill of Lading), PayPal, and Letter of Credit (L/C at sight). For qualified corporate accounts, net‑30 terms are negotiable after the first successful order.
All shipments are packed in **ISO‑compliant, temperature‑controlled containers**. We provide a complete customs dossier (COA, MSDS, Certificate of Origin) to ensure smooth clearance in the USA, Canada, EU, and APAC markets.
Our technical support team is on‑call 24 h (GMT +8) via email, WhatsApp, or WeChat. We offer free re‑analysis within 30 days if the product does not meet the stated specifications.
Only **50 samples** available – secure yours before they run out. Risk‑Free: If the sample does not meet your purity requirement, we’ll issue a full refund.
Request Free Sample NowOr call us directly at +86 199 4383 0844 for a live quote.
Emily Wang, Senior Chemist – Pharmatech USA
“The speed of delivery was a game‑changer. We received the hormone in 9 days and started the GLP‑1 assay the same week. Our timeline shaved off **2 months**.”
Dr. Michael O’Connor – Head of R&D, BioSphere (UK)
“The purity data matched the CoA perfectly. No re‑runs needed, saving us **≈ $60 K** in labor.”
Laura Kim – Procurement Lead, MedGen Labs (Australia)
“Transparent pricing and the ability to pay via L/C made the purchase process painless. The money‑back guarantee gave us confidence to try a new supplier.”
Global Technology Co., Ltd | Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Social Proof – Trusted by Global Leaders in Diabetes Research
GHRP-2-GHRP-6-peptide-alternative-product Diabetes-drug-discovery-tool-treatment-efficacy CAS-398001-88-2-Degarelix Hexarelin-Acetate-CAS-140703-51-1-growth-hormone-secretagogue
Dr. Sarah Lee, PhD – Lead Scientist, NovoGen Therapeutics (USA)
“Switching to Global Technology’s Incretin hormone cut our assay‑to‑report time by **28 %**. The batch‑to‑batch consistency let us publish three papers within a single year.”
James Patel, Procurement Manager – BioNova Labs (Canada)
“The price advantage (≈ 35 % lower) allowed us to allocate funds to additional target‑validation studies without compromising quality.”
Dr. Mei Chen – Senior Researcher, Shanghai Institute of Materia Medica
“Fast 7‑day delivery meant our GLP‑1 analog project stayed on the critical path. No more weekend‑night shipping headaches.”
Compliance & Certifications: CE, FDA, ISO 9001, GMP, GMP‑DMF, RoHS, VDE, CB, GS, HACCP/GMP, IPPC. All documents available on request.
Join these industry leaders – request your CoA now →